358 related articles for article (PubMed ID: 11767232)
41. Improved postprandial glycemic control with Humalog Mix75/25 after a standard test meal in patients with type 2 diabetes mellitus.
Malone JK; Woodworth JR; Arora V; Yang H; Campaigne BN; Hallé JP; Yale JF; Grossman LD
Clin Ther; 2000 Feb; 22(2):222-30. PubMed ID: 10743981
[TBL] [Abstract][Full Text] [Related]
42. Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c. IOEZ Study Group.
Bastyr EJ; Stuart CA; Brodows RG; Schwartz S; Graf CJ; Zagar A; Robertson KE
Diabetes Care; 2000 Sep; 23(9):1236-41. PubMed ID: 10977012
[TBL] [Abstract][Full Text] [Related]
43. Effectiveness of human ultralente versus NPH insulin in providing basal insulin replacement for an insulin lispro multiple daily injection regimen. A double-blind randomized prospective trial. The Canadian Lispro Study Group.
Zinman B; Ross S; Campos RV; Strack T
Diabetes Care; 1999 Apr; 22(4):603-8. PubMed ID: 10189539
[TBL] [Abstract][Full Text] [Related]
44. [Spanish experience with insulin lispro].
Reviriego Fernández J
An Med Interna; 1998 Jul; 15(7):384-90. PubMed ID: 9710993
[TBL] [Abstract][Full Text] [Related]
45. Effect of two starting insulin regimens in patients with type II diabetes not controlled on a combination of oral antihyperglycemic medications.
Milicevic Z; Hancu N; Car N; Ivanyi T; Schwarzenhofer M; Jermendy G
Exp Clin Endocrinol Diabetes; 2009 May; 117(5):223-9. PubMed ID: 19301232
[TBL] [Abstract][Full Text] [Related]
46. Mealtime treatment with insulin analog improves postprandial hyperglycemia and hypoglycemia in patients with non-insulin-dependent diabetes mellitus. Multicenter Insulin Lispro Study Group.
Anderson JH; Brunelle RL; Keohane P; Koivisto VA; Trautmann ME; Vignati L; DiMarchi R
Arch Intern Med; 1997 Jun; 157(11):1249-55. PubMed ID: 9183237
[TBL] [Abstract][Full Text] [Related]
47. Improvement of HbA1c and blood glucose stability in IDDM patients treated with lispro insulin analog in external pumps.
Melki V; Renard E; Lassmann-Vague V; Boivin S; Guerci B; Hanaire-Broutin H; Bringer J; Belicar P; Jeandidier N; Meyer L; Blin P; Augendre-Ferrante B; Tauber JP
Diabetes Care; 1998 Jun; 21(6):977-82. PubMed ID: 9614617
[TBL] [Abstract][Full Text] [Related]
48. Post-prandial insulin lispro vs. human regular insulin in prepubertal children with Type 1 diabetes mellitus.
Tupola S; Komulainen J; Jääskeläinen J; Sipilä I
Diabet Med; 2001 Aug; 18(8):654-8. PubMed ID: 11553203
[TBL] [Abstract][Full Text] [Related]
49. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity.
Malmberg K; Rydén L; Wedel H; Birkeland K; Bootsma A; Dickstein K; Efendic S; Fisher M; Hamsten A; Herlitz J; Hildebrandt P; MacLeod K; Laakso M; Torp-Pedersen C; Waldenström A;
Eur Heart J; 2005 Apr; 26(7):650-61. PubMed ID: 15728645
[TBL] [Abstract][Full Text] [Related]
50. Improvement in bedtime plasma glucose level serves as a predictor of long-term blood glucose control in patients with Type 2 diabetes: a study with monotherapy of 50/50 premixed insulin analogue three times daily injection.
Tanaka M; Ishii H
J Diabetes Complications; 2011; 25(2):83-9. PubMed ID: 20573523
[TBL] [Abstract][Full Text] [Related]
51. Insulin lispro in CSII: results of a double-blind crossover study.
Zinman B; Tildesley H; Chiasson JL; Tsui E; Strack T
Diabetes; 1997 Mar; 46(3):440-3. PubMed ID: 9032100
[TBL] [Abstract][Full Text] [Related]
52. Initiating insulin treatment in insulin-requiring type 2 diabetic patients: comparative efficiency and cost of outpatient and inpatient management. INNOV Study Group.
Penfornis A; Millot L
Diabetes Metab; 1998 Apr; 24(2):137-42. PubMed ID: 9592638
[TBL] [Abstract][Full Text] [Related]
53. Insulin analog lispro decreases insulin resistance and improves glycemic control in an obese patient with insulin-requiring type 2 diabetes.
Darmon P; Curtillet C; Boullu S; Laugier A; Dutour A; Oliver C
Diabetes Care; 1998 Sep; 21(9):1575. PubMed ID: 9727917
[No Abstract] [Full Text] [Related]
54. Intensive insulin therapy with insulin lispro in patients with type 1 diabetes reduces the frequency of hypoglycemic episodes.
Pfützner A; Küstner E; Forst T; Schulze-Schleppinghoff B; Trautmann ME; Haslbeck M; Schatz H; Beyer J
Exp Clin Endocrinol Diabetes; 1996; 104(1):25-30. PubMed ID: 8750567
[TBL] [Abstract][Full Text] [Related]
55. [Diabetes mellitus type II: when convert to insulin?].
Bianda TL; Spinas GA
Praxis (Bern 1994); 1997 Sep; 86(38):1453-7. PubMed ID: 9381045
[TBL] [Abstract][Full Text] [Related]
56. [Combined insulin-sulfonylurea in type II diabetes mellitus--an update].
Ravina A; Minuchin O
Harefuah; 1987 Nov; 113(10):285-7. PubMed ID: 3326798
[No Abstract] [Full Text] [Related]
57. Improved blood glucose variability, HbA1c insuman Infusat and less insulin requirement in IDDM patients using insulin lispro in CSII. The Swedish Multicenter Lispro Insulin Study.
Johansson UB; Adamson UC; Lins PE; Wredling RA
Diabetes Metab; 2000 May; 26(3):192-6. PubMed ID: 10880892
[TBL] [Abstract][Full Text] [Related]
58. [Minor differences in outcome comparing early vs. later initiation of medicamentous blood glucose control in type 2 diabetic patients].
Ritzman P
Praxis (Bern 1994); 1999 Aug; 88(31-32):1289-90. PubMed ID: 10479970
[No Abstract] [Full Text] [Related]
59. [Lispro mixed insulins in type 2 diabetes. Preventing postprandial insulin rise].
MMW Fortschr Med; 2000 Jul; 142(28-29):58-9. PubMed ID: 10959169
[No Abstract] [Full Text] [Related]
60. Guidelines for premeal insulin dose reduction for postprandial exercise of different intensities and durations in type 1 diabetic subjects treated intensively with a basal-bolus insulin regimen (ultralente-lispro).
Rabasa-Lhoret R; Bourque J; Ducros F; Chiasson JL
Diabetes Care; 2001 Apr; 24(4):625-30. PubMed ID: 11315820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
